nodes	percent_of_prediction	percent_of_DWPC	metapath
Busulfan—GSTA1—gall bladder—colon cancer	0.0237	0.0762	CbGeAlD
Busulfan—GSTM1—blood vessel—colon cancer	0.0187	0.0599	CbGeAlD
Busulfan—GSTA2—gall bladder—colon cancer	0.0171	0.055	CbGeAlD
Busulfan—GSTA1—embryo—colon cancer	0.015	0.0483	CbGeAlD
Busulfan—MGST2—renal system—colon cancer	0.0134	0.043	CbGeAlD
Busulfan—MGST2—Metapathway biotransformation—CHST4—colon cancer	0.0126	0.158	CbGpPWpGaD
Busulfan—GSTA1—epithelium—colon cancer	0.0123	0.0394	CbGeAlD
Busulfan—GSTA1—renal system—colon cancer	0.0114	0.0366	CbGeAlD
Busulfan—GSTP1—gall bladder—colon cancer	0.011	0.0353	CbGeAlD
Busulfan—GSTA2—embryo—colon cancer	0.0109	0.0349	CbGeAlD
Busulfan—MGST2—bone marrow—colon cancer	0.0101	0.0325	CbGeAlD
Busulfan—MGST2—vagina—colon cancer	0.0097	0.0311	CbGeAlD
Busulfan—GSTA1—lymphoid tissue—colon cancer	0.00946	0.0304	CbGeAlD
Busulfan—GSTA1—digestive system—colon cancer	0.00934	0.03	CbGeAlD
Busulfan—GSTA2—epithelium—colon cancer	0.00886	0.0284	CbGeAlD
Busulfan—GSTM1—renal system—colon cancer	0.00842	0.027	CbGeAlD
Busulfan—GSTA2—renal system—colon cancer	0.00822	0.0264	CbGeAlD
Busulfan—MGST2—liver—colon cancer	0.00818	0.0263	CbGeAlD
Busulfan—GSTM1—Metapathway biotransformation—CHST4—colon cancer	0.00703	0.0881	CbGpPWpGaD
Busulfan—GSTM1—lymphoid tissue—colon cancer	0.00699	0.0225	CbGeAlD
Busulfan—GSTP1—embryo—colon cancer	0.00697	0.0224	CbGeAlD
Busulfan—GSTA1—liver—colon cancer	0.00696	0.0223	CbGeAlD
Busulfan—GSTM1—digestive system—colon cancer	0.00691	0.0222	CbGeAlD
Busulfan—GSTA2—lymphoid tissue—colon cancer	0.00682	0.0219	CbGeAlD
Busulfan—GSTA2—digestive system—colon cancer	0.00674	0.0216	CbGeAlD
Busulfan—MGST2—lymph node—colon cancer	0.00627	0.0201	CbGeAlD
Busulfan—GSTP1—Metapathway biotransformation—CHST4—colon cancer	0.00598	0.0749	CbGpPWpGaD
Busulfan—MGST2—Metapathway biotransformation—CHST5—colon cancer	0.00578	0.0724	CbGpPWpGaD
Busulfan—GSTP1—epithelium—colon cancer	0.00569	0.0183	CbGeAlD
Busulfan—GSTP1—smooth muscle tissue—colon cancer	0.00548	0.0176	CbGeAlD
Busulfan—GSTP1—renal system—colon cancer	0.00528	0.0169	CbGeAlD
Busulfan—GSTM1—liver—colon cancer	0.00515	0.0165	CbGeAlD
Busulfan—GSTA2—liver—colon cancer	0.00502	0.0161	CbGeAlD
Busulfan—GSTP1—lymphoid tissue—colon cancer	0.00438	0.0141	CbGeAlD
Busulfan—GSTP1—digestive system—colon cancer	0.00433	0.0139	CbGeAlD
Busulfan—GSTP1—bone marrow—colon cancer	0.00399	0.0128	CbGeAlD
Busulfan—GSTM1—lymph node—colon cancer	0.00395	0.0127	CbGeAlD
Busulfan—GSTP1—vagina—colon cancer	0.00382	0.0123	CbGeAlD
Busulfan—GSTA2—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.00341	0.0428	CbGpPWpGaD
Busulfan—GSTM1—Metapathway biotransformation—CHST5—colon cancer	0.00323	0.0404	CbGpPWpGaD
Busulfan—GSTP1—liver—colon cancer	0.00322	0.0104	CbGeAlD
Busulfan—GSTP1—Metapathway biotransformation—CHST5—colon cancer	0.00274	0.0344	CbGpPWpGaD
Busulfan—GSTP1—lymph node—colon cancer	0.00247	0.00794	CbGeAlD
Busulfan—GSTA2—Aryl Hydrocarbon Receptor Pathway—BAX—colon cancer	0.00242	0.0303	CbGpPWpGaD
Busulfan—CYP3A4—renal system—colon cancer	0.00215	0.00691	CbGeAlD
Busulfan—GSTA2—Transcriptional activation by NRF2—PIK3CA—colon cancer	0.00211	0.0264	CbGpPWpGaD
Busulfan—CYP3A4—digestive system—colon cancer	0.00176	0.00566	CbGeAlD
Busulfan—MGST2—Metabolism—CA7—colon cancer	0.00165	0.0207	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—CA7—colon cancer	0.00141	0.0176	CbGpPWpGaD
Busulfan—CYP3A4—liver—colon cancer	0.00131	0.00422	CbGeAlD
Busulfan—CYP3A4—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.00121	0.0152	CbGpPWpGaD
Busulfan—GSTA2—Aryl Hydrocarbon Receptor Pathway—EP300—colon cancer	0.00116	0.0146	CbGpPWpGaD
Busulfan—GSTA2—Aryl Hydrocarbon Receptor Pathway—SRC—colon cancer	0.00113	0.0142	CbGpPWpGaD
Busulfan—GSTA2—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	0.00101	0.0127	CbGpPWpGaD
Busulfan—MGST2—Metabolism—ODC1—colon cancer	0.001	0.0125	CbGpPWpGaD
Busulfan—MGST2—Metabolism—CHST5—colon cancer	0.001	0.0125	CbGpPWpGaD
Busulfan—GSTA2—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	0.000991	0.0124	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—CA7—colon cancer	0.000949	0.0119	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—CA7—colon cancer	0.000924	0.0116	CbGpPWpGaD
Busulfan—Leukopenia—Vincristine—colon cancer	0.000896	0.00147	CcSEcCtD
Busulfan—Pancytopenia—Capecitabine—colon cancer	0.000889	0.00146	CcSEcCtD
Busulfan—Dysuria—Capecitabine—colon cancer	0.000876	0.00144	CcSEcCtD
Busulfan—Neutropenia—Capecitabine—colon cancer	0.000876	0.00144	CcSEcCtD
Busulfan—Leukopenia—Irinotecan—colon cancer	0.000873	0.00143	CcSEcCtD
Busulfan—Convulsion—Vincristine—colon cancer	0.000867	0.00142	CcSEcCtD
Busulfan—Hypertension—Vincristine—colon cancer	0.000864	0.00142	CcSEcCtD
Busulfan—Anaemia—Fluorouracil—colon cancer	0.000863	0.00142	CcSEcCtD
Busulfan—Dermatitis exfoliative—Methotrexate—colon cancer	0.000855	0.0014	CcSEcCtD
Busulfan—Myalgia—Vincristine—colon cancer	0.000852	0.0014	CcSEcCtD
Busulfan—Weight increased—Capecitabine—colon cancer	0.000852	0.0014	CcSEcCtD
Busulfan—GSTA1—Metabolism—ODC1—colon cancer	0.000852	0.0107	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—CHST5—colon cancer	0.000852	0.0107	CbGpPWpGaD
Busulfan—Cough—Irinotecan—colon cancer	0.000851	0.0014	CcSEcCtD
Busulfan—CYP3A4—Metapathway biotransformation—CHST4—colon cancer	0.000848	0.0106	CbGpPWpGaD
Busulfan—Weight decreased—Capecitabine—colon cancer	0.000847	0.00139	CcSEcCtD
Busulfan—Hyperglycaemia—Capecitabine—colon cancer	0.000845	0.00139	CcSEcCtD
Busulfan—Hypertension—Irinotecan—colon cancer	0.000842	0.00138	CcSEcCtD
Busulfan—Pneumonia—Capecitabine—colon cancer	0.00084	0.00138	CcSEcCtD
Busulfan—GSTM1—C-MYB transcription factor network—PTGS2—colon cancer	0.00084	0.0105	CbGpPWpGaD
Busulfan—Leukopenia—Fluorouracil—colon cancer	0.000836	0.00137	CcSEcCtD
Busulfan—Infestation NOS—Capecitabine—colon cancer	0.000835	0.00137	CcSEcCtD
Busulfan—Infestation—Capecitabine—colon cancer	0.000835	0.00137	CcSEcCtD
Busulfan—Depression—Capecitabine—colon cancer	0.000833	0.00137	CcSEcCtD
Busulfan—Lethargy—Methotrexate—colon cancer	0.000823	0.00135	CcSEcCtD
Busulfan—Renal failure—Capecitabine—colon cancer	0.000821	0.00135	CcSEcCtD
Busulfan—Oedema—Vincristine—colon cancer	0.000817	0.00134	CcSEcCtD
Busulfan—Stomatitis—Capecitabine—colon cancer	0.000814	0.00134	CcSEcCtD
Busulfan—Jaundice—Capecitabine—colon cancer	0.000814	0.00134	CcSEcCtD
Busulfan—Infection—Vincristine—colon cancer	0.000812	0.00133	CcSEcCtD
Busulfan—Convulsion—Fluorouracil—colon cancer	0.000809	0.00133	CcSEcCtD
Busulfan—Confusional state—Irinotecan—colon cancer	0.000802	0.00132	CcSEcCtD
Busulfan—Nervous system disorder—Vincristine—colon cancer	0.000801	0.00132	CcSEcCtD
Busulfan—Thrombocytopenia—Vincristine—colon cancer	0.0008	0.00131	CcSEcCtD
Busulfan—Haematuria—Capecitabine—colon cancer	0.000796	0.00131	CcSEcCtD
Busulfan—Oedema—Irinotecan—colon cancer	0.000796	0.00131	CcSEcCtD
Busulfan—Chest pain—Fluorouracil—colon cancer	0.000795	0.00131	CcSEcCtD
Busulfan—Myalgia—Fluorouracil—colon cancer	0.000795	0.00131	CcSEcCtD
Busulfan—Infection—Irinotecan—colon cancer	0.000791	0.0013	CcSEcCtD
Busulfan—Hepatobiliary disease—Capecitabine—colon cancer	0.00079	0.0013	CcSEcCtD
Busulfan—Epistaxis—Capecitabine—colon cancer	0.000788	0.00129	CcSEcCtD
Busulfan—GSTP1—Metabolism—CA7—colon cancer	0.000785	0.00984	CbGpPWpGaD
Busulfan—Nervous system disorder—Irinotecan—colon cancer	0.00078	0.00128	CcSEcCtD
Busulfan—Agranulocytosis—Capecitabine—colon cancer	0.000779	0.00128	CcSEcCtD
Busulfan—Thrombocytopenia—Irinotecan—colon cancer	0.000779	0.00128	CcSEcCtD
Busulfan—Anorexia—Vincristine—colon cancer	0.000779	0.00128	CcSEcCtD
Busulfan—Confusional state—Fluorouracil—colon cancer	0.000768	0.00126	CcSEcCtD
Busulfan—Hypotension—Vincristine—colon cancer	0.000763	0.00125	CcSEcCtD
Busulfan—Bradycardia—Capecitabine—colon cancer	0.000763	0.00125	CcSEcCtD
Busulfan—Oedema—Fluorouracil—colon cancer	0.000762	0.00125	CcSEcCtD
Busulfan—GSTM1—C-MYB transcription factor network—CCND1—colon cancer	0.000759	0.00951	CbGpPWpGaD
Busulfan—Anorexia—Irinotecan—colon cancer	0.000759	0.00125	CcSEcCtD
Busulfan—Infection—Fluorouracil—colon cancer	0.000757	0.00124	CcSEcCtD
Busulfan—Haemoglobin—Capecitabine—colon cancer	0.000753	0.00124	CcSEcCtD
Busulfan—Rhinitis—Capecitabine—colon cancer	0.000752	0.00123	CcSEcCtD
Busulfan—Haemorrhage—Capecitabine—colon cancer	0.00075	0.00123	CcSEcCtD
Busulfan—Nervous system disorder—Fluorouracil—colon cancer	0.000747	0.00123	CcSEcCtD
Busulfan—Thrombocytopenia—Fluorouracil—colon cancer	0.000746	0.00123	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Vincristine—colon cancer	0.000744	0.00122	CcSEcCtD
Busulfan—Pharyngitis—Capecitabine—colon cancer	0.000744	0.00122	CcSEcCtD
Busulfan—Tachycardia—Fluorouracil—colon cancer	0.000744	0.00122	CcSEcCtD
Busulfan—Hypotension—Irinotecan—colon cancer	0.000744	0.00122	CcSEcCtD
Busulfan—Urinary tract disorder—Capecitabine—colon cancer	0.00074	0.00122	CcSEcCtD
Busulfan—Insomnia—Vincristine—colon cancer	0.000739	0.00121	CcSEcCtD
Busulfan—Connective tissue disorder—Capecitabine—colon cancer	0.000737	0.00121	CcSEcCtD
Busulfan—Urethral disorder—Capecitabine—colon cancer	0.000735	0.00121	CcSEcCtD
Busulfan—GSTM1—C-MYB transcription factor network—CDKN1A—colon cancer	0.000734	0.0092	CbGpPWpGaD
Busulfan—Anorexia—Fluorouracil—colon cancer	0.000726	0.00119	CcSEcCtD
Busulfan—Insomnia—Irinotecan—colon cancer	0.00072	0.00118	CcSEcCtD
Busulfan—Hypotension—Fluorouracil—colon cancer	0.000712	0.00117	CcSEcCtD
Busulfan—Decreased appetite—Vincristine—colon cancer	0.00071	0.00117	CcSEcCtD
Busulfan—Dyspnoea—Irinotecan—colon cancer	0.000709	0.00117	CcSEcCtD
Busulfan—Erythema multiforme—Capecitabine—colon cancer	0.000709	0.00116	CcSEcCtD
Busulfan—Somnolence—Irinotecan—colon cancer	0.000707	0.00116	CcSEcCtD
Busulfan—Gastrointestinal disorder—Vincristine—colon cancer	0.000705	0.00116	CcSEcCtD
Busulfan—Fatigue—Vincristine—colon cancer	0.000704	0.00116	CcSEcCtD
Busulfan—Eye disorder—Capecitabine—colon cancer	0.000701	0.00115	CcSEcCtD
Busulfan—Dyspepsia—Irinotecan—colon cancer	0.0007	0.00115	CcSEcCtD
Busulfan—Pain—Vincristine—colon cancer	0.000699	0.00115	CcSEcCtD
Busulfan—Constipation—Vincristine—colon cancer	0.000699	0.00115	CcSEcCtD
Busulfan—GSTM1—C-MYB transcription factor network—EP300—colon cancer	0.000698	0.00875	CbGpPWpGaD
Busulfan—MGST2—NRF2 pathway—TGFB1—colon cancer	0.000698	0.00875	CbGpPWpGaD
Busulfan—Asthma—Methotrexate—colon cancer	0.000697	0.00115	CcSEcCtD
Busulfan—Flushing—Capecitabine—colon cancer	0.000696	0.00114	CcSEcCtD
Busulfan—Cardiac disorder—Capecitabine—colon cancer	0.000696	0.00114	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000694	0.00114	CcSEcCtD
Busulfan—Decreased appetite—Irinotecan—colon cancer	0.000692	0.00114	CcSEcCtD
Busulfan—Insomnia—Fluorouracil—colon cancer	0.000689	0.00113	CcSEcCtD
Busulfan—Gastrointestinal disorder—Irinotecan—colon cancer	0.000687	0.00113	CcSEcCtD
Busulfan—Fatigue—Irinotecan—colon cancer	0.000686	0.00113	CcSEcCtD
Busulfan—Pancreatitis—Methotrexate—colon cancer	0.000684	0.00112	CcSEcCtD
Busulfan—Pain—Irinotecan—colon cancer	0.00068	0.00112	CcSEcCtD
Busulfan—Constipation—Irinotecan—colon cancer	0.00068	0.00112	CcSEcCtD
Busulfan—Angiopathy—Capecitabine—colon cancer	0.00068	0.00112	CcSEcCtD
Busulfan—Dyspnoea—Fluorouracil—colon cancer	0.000679	0.00112	CcSEcCtD
Busulfan—Somnolence—Fluorouracil—colon cancer	0.000678	0.00111	CcSEcCtD
Busulfan—Immune system disorder—Capecitabine—colon cancer	0.000677	0.00111	CcSEcCtD
Busulfan—Mediastinal disorder—Capecitabine—colon cancer	0.000676	0.00111	CcSEcCtD
Busulfan—Chills—Capecitabine—colon cancer	0.000673	0.0011	CcSEcCtD
Busulfan—Dyspepsia—Fluorouracil—colon cancer	0.000671	0.0011	CcSEcCtD
Busulfan—Arrhythmia—Capecitabine—colon cancer	0.00067	0.0011	CcSEcCtD
Busulfan—Gastrointestinal pain—Vincristine—colon cancer	0.000668	0.0011	CcSEcCtD
Busulfan—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.000664	0.00832	CbGpPWpGaD
Busulfan—Decreased appetite—Fluorouracil—colon cancer	0.000663	0.00109	CcSEcCtD
Busulfan—Alopecia—Capecitabine—colon cancer	0.000662	0.00109	CcSEcCtD
Busulfan—Pancytopenia—Methotrexate—colon cancer	0.000662	0.00109	CcSEcCtD
Busulfan—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000658	0.00108	CcSEcCtD
Busulfan—Mental disorder—Capecitabine—colon cancer	0.000657	0.00108	CcSEcCtD
Busulfan—Feeling abnormal—Irinotecan—colon cancer	0.000656	0.00108	CcSEcCtD
Busulfan—GSTM1—C-MYB transcription factor network—NRAS—colon cancer	0.000653	0.00819	CbGpPWpGaD
Busulfan—Erythema—Capecitabine—colon cancer	0.000653	0.00107	CcSEcCtD
Busulfan—Malnutrition—Capecitabine—colon cancer	0.000653	0.00107	CcSEcCtD
Busulfan—Neutropenia—Methotrexate—colon cancer	0.000652	0.00107	CcSEcCtD
Busulfan—Dysuria—Methotrexate—colon cancer	0.000652	0.00107	CcSEcCtD
Busulfan—Pain—Fluorouracil—colon cancer	0.000652	0.00107	CcSEcCtD
Busulfan—Gastrointestinal pain—Irinotecan—colon cancer	0.000651	0.00107	CcSEcCtD
Busulfan—Body temperature increased—Vincristine—colon cancer	0.000646	0.00106	CcSEcCtD
Busulfan—Abdominal pain—Vincristine—colon cancer	0.000646	0.00106	CcSEcCtD
Busulfan—Erectile dysfunction—Methotrexate—colon cancer	0.000642	0.00105	CcSEcCtD
Busulfan—Back pain—Capecitabine—colon cancer	0.000631	0.00104	CcSEcCtD
Busulfan—Body temperature increased—Irinotecan—colon cancer	0.000629	0.00103	CcSEcCtD
Busulfan—Abdominal pain—Irinotecan—colon cancer	0.000629	0.00103	CcSEcCtD
Busulfan—Feeling abnormal—Fluorouracil—colon cancer	0.000628	0.00103	CcSEcCtD
Busulfan—Pneumonia—Methotrexate—colon cancer	0.000625	0.00103	CcSEcCtD
Busulfan—Infestation—Methotrexate—colon cancer	0.000622	0.00102	CcSEcCtD
Busulfan—Infestation NOS—Methotrexate—colon cancer	0.000622	0.00102	CcSEcCtD
Busulfan—Depression—Methotrexate—colon cancer	0.00062	0.00102	CcSEcCtD
Busulfan—Renal failure—Methotrexate—colon cancer	0.000611	0.001	CcSEcCtD
Busulfan—GSTM1—C-MYB transcription factor network—MYC—colon cancer	0.000609	0.00762	CbGpPWpGaD
Busulfan—Stomatitis—Methotrexate—colon cancer	0.000606	0.000995	CcSEcCtD
Busulfan—Urticaria—Fluorouracil—colon cancer	0.000605	0.000995	CcSEcCtD
Busulfan—Anaemia—Capecitabine—colon cancer	0.000603	0.000991	CcSEcCtD
Busulfan—Body temperature increased—Fluorouracil—colon cancer	0.000602	0.00099	CcSEcCtD
Busulfan—Hypersensitivity—Vincristine—colon cancer	0.000602	0.000989	CcSEcCtD
Busulfan—GSTA1—NRF2 pathway—TGFB1—colon cancer	0.000594	0.00744	CbGpPWpGaD
Busulfan—Haematuria—Methotrexate—colon cancer	0.000593	0.000974	CcSEcCtD
Busulfan—Hepatobiliary disease—Methotrexate—colon cancer	0.000588	0.000966	CcSEcCtD
Busulfan—Epistaxis—Methotrexate—colon cancer	0.000586	0.000963	CcSEcCtD
Busulfan—Hypersensitivity—Irinotecan—colon cancer	0.000586	0.000963	CcSEcCtD
Busulfan—Asthenia—Vincristine—colon cancer	0.000586	0.000963	CcSEcCtD
Busulfan—Leukopenia—Capecitabine—colon cancer	0.000584	0.00096	CcSEcCtD
Busulfan—Agranulocytosis—Methotrexate—colon cancer	0.00058	0.000953	CcSEcCtD
Busulfan—GSTA2—Metabolism—CHST5—colon cancer	0.000575	0.00721	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—ODC1—colon cancer	0.000575	0.00721	CbGpPWpGaD
Busulfan—Asthenia—Irinotecan—colon cancer	0.000571	0.000938	CcSEcCtD
Busulfan—Cough—Capecitabine—colon cancer	0.000569	0.000935	CcSEcCtD
Busulfan—Hypertension—Capecitabine—colon cancer	0.000563	0.000925	CcSEcCtD
Busulfan—GSTM1—C-MYB transcription factor network—KRAS—colon cancer	0.000562	0.00704	CbGpPWpGaD
Busulfan—Hypersensitivity—Fluorouracil—colon cancer	0.000561	0.000922	CcSEcCtD
Busulfan—Haemoglobin—Methotrexate—colon cancer	0.000561	0.000921	CcSEcCtD
Busulfan—GSTM1—Metabolism—ODC1—colon cancer	0.00056	0.00701	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—CHST5—colon cancer	0.00056	0.00701	CbGpPWpGaD
Busulfan—CYP3A4—Irinotecan Pathway—APC—colon cancer	0.000559	0.00701	CbGpPWpGaD
Busulfan—Diarrhoea—Vincristine—colon cancer	0.000559	0.000918	CcSEcCtD
Busulfan—Haemorrhage—Methotrexate—colon cancer	0.000558	0.000917	CcSEcCtD
Busulfan—Chest pain—Capecitabine—colon cancer	0.000556	0.000913	CcSEcCtD
Busulfan—Myalgia—Capecitabine—colon cancer	0.000556	0.000913	CcSEcCtD
Busulfan—Arthralgia—Capecitabine—colon cancer	0.000556	0.000913	CcSEcCtD
Busulfan—Pharyngitis—Methotrexate—colon cancer	0.000554	0.00091	CcSEcCtD
Busulfan—Anxiety—Capecitabine—colon cancer	0.000554	0.000909	CcSEcCtD
Busulfan—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000552	0.000906	CcSEcCtD
Busulfan—Urinary tract disorder—Methotrexate—colon cancer	0.000551	0.000905	CcSEcCtD
Busulfan—Urethral disorder—Methotrexate—colon cancer	0.000547	0.000899	CcSEcCtD
Busulfan—Diarrhoea—Irinotecan—colon cancer	0.000544	0.000894	CcSEcCtD
Busulfan—Dry mouth—Capecitabine—colon cancer	0.000543	0.000893	CcSEcCtD
Busulfan—Dizziness—Vincristine—colon cancer	0.00054	0.000888	CcSEcCtD
Busulfan—Pruritus—Fluorouracil—colon cancer	0.000539	0.000886	CcSEcCtD
Busulfan—Confusional state—Capecitabine—colon cancer	0.000537	0.000882	CcSEcCtD
Busulfan—Oedema—Capecitabine—colon cancer	0.000533	0.000875	CcSEcCtD
Busulfan—Infection—Capecitabine—colon cancer	0.000529	0.000869	CcSEcCtD
Busulfan—Erythema multiforme—Methotrexate—colon cancer	0.000528	0.000867	CcSEcCtD
Busulfan—Dizziness—Irinotecan—colon cancer	0.000526	0.000864	CcSEcCtD
Busulfan—Nervous system disorder—Capecitabine—colon cancer	0.000522	0.000858	CcSEcCtD
Busulfan—Eye disorder—Methotrexate—colon cancer	0.000521	0.000857	CcSEcCtD
Busulfan—Diarrhoea—Fluorouracil—colon cancer	0.000521	0.000857	CcSEcCtD
Busulfan—Thrombocytopenia—Capecitabine—colon cancer	0.000521	0.000857	CcSEcCtD
Busulfan—Tachycardia—Capecitabine—colon cancer	0.00052	0.000854	CcSEcCtD
Busulfan—Vomiting—Vincristine—colon cancer	0.00052	0.000853	CcSEcCtD
Busulfan—Cardiac disorder—Methotrexate—colon cancer	0.000518	0.000851	CcSEcCtD
Busulfan—Skin disorder—Capecitabine—colon cancer	0.000517	0.00085	CcSEcCtD
Busulfan—Rash—Vincristine—colon cancer	0.000515	0.000846	CcSEcCtD
Busulfan—Dermatitis—Vincristine—colon cancer	0.000515	0.000846	CcSEcCtD
Busulfan—Headache—Vincristine—colon cancer	0.000512	0.000841	CcSEcCtD
Busulfan—Anorexia—Capecitabine—colon cancer	0.000508	0.000834	CcSEcCtD
Busulfan—Angiopathy—Methotrexate—colon cancer	0.000506	0.000832	CcSEcCtD
Busulfan—Vomiting—Irinotecan—colon cancer	0.000506	0.000831	CcSEcCtD
Busulfan—Immune system disorder—Methotrexate—colon cancer	0.000504	0.000828	CcSEcCtD
Busulfan—Dizziness—Fluorouracil—colon cancer	0.000504	0.000828	CcSEcCtD
Busulfan—Mediastinal disorder—Methotrexate—colon cancer	0.000503	0.000826	CcSEcCtD
Busulfan—Rash—Irinotecan—colon cancer	0.000502	0.000824	CcSEcCtD
Busulfan—Dermatitis—Irinotecan—colon cancer	0.000501	0.000823	CcSEcCtD
Busulfan—Chills—Methotrexate—colon cancer	0.000501	0.000823	CcSEcCtD
Busulfan—Headache—Irinotecan—colon cancer	0.000498	0.000819	CcSEcCtD
Busulfan—Hypotension—Capecitabine—colon cancer	0.000498	0.000817	CcSEcCtD
Busulfan—Alopecia—Methotrexate—colon cancer	0.000493	0.00081	CcSEcCtD
Busulfan—Mental disorder—Methotrexate—colon cancer	0.000489	0.000803	CcSEcCtD
Busulfan—Erythema—Methotrexate—colon cancer	0.000486	0.000798	CcSEcCtD
Busulfan—Malnutrition—Methotrexate—colon cancer	0.000486	0.000798	CcSEcCtD
Busulfan—Nausea—Vincristine—colon cancer	0.000485	0.000797	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000485	0.000797	CcSEcCtD
Busulfan—Vomiting—Fluorouracil—colon cancer	0.000485	0.000796	CcSEcCtD
Busulfan—Insomnia—Capecitabine—colon cancer	0.000482	0.000791	CcSEcCtD
Busulfan—Rash—Fluorouracil—colon cancer	0.000481	0.000789	CcSEcCtD
Busulfan—Dermatitis—Fluorouracil—colon cancer	0.00048	0.000789	CcSEcCtD
Busulfan—GSTM1—C-MYB transcription factor network—HRAS—colon cancer	0.000478	0.00599	CbGpPWpGaD
Busulfan—Headache—Fluorouracil—colon cancer	0.000477	0.000784	CcSEcCtD
Busulfan—GSTP1—Metabolism—ODC1—colon cancer	0.000476	0.00596	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—CHST5—colon cancer	0.000476	0.00596	CbGpPWpGaD
Busulfan—Dyspnoea—Capecitabine—colon cancer	0.000475	0.00078	CcSEcCtD
Busulfan—Nausea—Irinotecan—colon cancer	0.000473	0.000776	CcSEcCtD
Busulfan—Back pain—Methotrexate—colon cancer	0.00047	0.000772	CcSEcCtD
Busulfan—Dyspepsia—Capecitabine—colon cancer	0.000469	0.00077	CcSEcCtD
Busulfan—Decreased appetite—Capecitabine—colon cancer	0.000463	0.000761	CcSEcCtD
Busulfan—Gastrointestinal disorder—Capecitabine—colon cancer	0.00046	0.000755	CcSEcCtD
Busulfan—Fatigue—Capecitabine—colon cancer	0.000459	0.000754	CcSEcCtD
Busulfan—Pain—Capecitabine—colon cancer	0.000455	0.000748	CcSEcCtD
Busulfan—Constipation—Capecitabine—colon cancer	0.000455	0.000748	CcSEcCtD
Busulfan—Nausea—Fluorouracil—colon cancer	0.000453	0.000744	CcSEcCtD
Busulfan—Anaemia—Methotrexate—colon cancer	0.000449	0.000738	CcSEcCtD
Busulfan—Feeling abnormal—Capecitabine—colon cancer	0.000439	0.000721	CcSEcCtD
Busulfan—Gastrointestinal pain—Capecitabine—colon cancer	0.000435	0.000715	CcSEcCtD
Busulfan—Leukopenia—Methotrexate—colon cancer	0.000435	0.000714	CcSEcCtD
Busulfan—Cough—Methotrexate—colon cancer	0.000424	0.000696	CcSEcCtD
Busulfan—Urticaria—Capecitabine—colon cancer	0.000423	0.000695	CcSEcCtD
Busulfan—Abdominal pain—Capecitabine—colon cancer	0.000421	0.000692	CcSEcCtD
Busulfan—Body temperature increased—Capecitabine—colon cancer	0.000421	0.000692	CcSEcCtD
Busulfan—Convulsion—Methotrexate—colon cancer	0.000421	0.000691	CcSEcCtD
Busulfan—Arthralgia—Methotrexate—colon cancer	0.000414	0.000679	CcSEcCtD
Busulfan—Myalgia—Methotrexate—colon cancer	0.000414	0.000679	CcSEcCtD
Busulfan—Chest pain—Methotrexate—colon cancer	0.000414	0.000679	CcSEcCtD
Busulfan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000411	0.000675	CcSEcCtD
Busulfan—GSTA2—NRF2 pathway—TGFB1—colon cancer	0.000401	0.00502	CbGpPWpGaD
Busulfan—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000401	0.00502	CbGpPWpGaD
Busulfan—Confusional state—Methotrexate—colon cancer	0.0004	0.000657	CcSEcCtD
Busulfan—Infection—Methotrexate—colon cancer	0.000394	0.000647	CcSEcCtD
Busulfan—Hypersensitivity—Capecitabine—colon cancer	0.000392	0.000645	CcSEcCtD
Busulfan—GSTM1—NRF2 pathway—TGFB1—colon cancer	0.00039	0.00489	CbGpPWpGaD
Busulfan—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	0.000389	0.00488	CbGpPWpGaD
Busulfan—Nervous system disorder—Methotrexate—colon cancer	0.000389	0.000639	CcSEcCtD
Busulfan—Thrombocytopenia—Methotrexate—colon cancer	0.000388	0.000638	CcSEcCtD
Busulfan—Skin disorder—Methotrexate—colon cancer	0.000385	0.000633	CcSEcCtD
Busulfan—Asthenia—Capecitabine—colon cancer	0.000382	0.000628	CcSEcCtD
Busulfan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000382	0.00478	CbGpPWpGaD
Busulfan—Anorexia—Methotrexate—colon cancer	0.000378	0.000621	CcSEcCtD
Busulfan—Pruritus—Capecitabine—colon cancer	0.000377	0.000619	CcSEcCtD
Busulfan—Hypotension—Methotrexate—colon cancer	0.00037	0.000609	CcSEcCtD
Busulfan—Diarrhoea—Capecitabine—colon cancer	0.000364	0.000599	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000361	0.000593	CcSEcCtD
Busulfan—Insomnia—Methotrexate—colon cancer	0.000359	0.000589	CcSEcCtD
Busulfan—Dyspnoea—Methotrexate—colon cancer	0.000353	0.000581	CcSEcCtD
Busulfan—Somnolence—Methotrexate—colon cancer	0.000352	0.000579	CcSEcCtD
Busulfan—Dizziness—Capecitabine—colon cancer	0.000352	0.000579	CcSEcCtD
Busulfan—Dyspepsia—Methotrexate—colon cancer	0.000349	0.000573	CcSEcCtD
Busulfan—Decreased appetite—Methotrexate—colon cancer	0.000345	0.000566	CcSEcCtD
Busulfan—Gastrointestinal disorder—Methotrexate—colon cancer	0.000342	0.000562	CcSEcCtD
Busulfan—Fatigue—Methotrexate—colon cancer	0.000342	0.000561	CcSEcCtD
Busulfan—Pain—Methotrexate—colon cancer	0.000339	0.000557	CcSEcCtD
Busulfan—Vomiting—Capecitabine—colon cancer	0.000339	0.000556	CcSEcCtD
Busulfan—Rash—Capecitabine—colon cancer	0.000336	0.000552	CcSEcCtD
Busulfan—Dermatitis—Capecitabine—colon cancer	0.000335	0.000551	CcSEcCtD
Busulfan—Headache—Capecitabine—colon cancer	0.000334	0.000548	CcSEcCtD
Busulfan—GSTP1—NRF2 pathway—TGFB1—colon cancer	0.000332	0.00416	CbGpPWpGaD
Busulfan—Feeling abnormal—Methotrexate—colon cancer	0.000327	0.000537	CcSEcCtD
Busulfan—Gastrointestinal pain—Methotrexate—colon cancer	0.000324	0.000533	CcSEcCtD
Busulfan—Nausea—Capecitabine—colon cancer	0.000316	0.00052	CcSEcCtD
Busulfan—Urticaria—Methotrexate—colon cancer	0.000315	0.000517	CcSEcCtD
Busulfan—Abdominal pain—Methotrexate—colon cancer	0.000313	0.000515	CcSEcCtD
Busulfan—Body temperature increased—Methotrexate—colon cancer	0.000313	0.000515	CcSEcCtD
Busulfan—Hypersensitivity—Methotrexate—colon cancer	0.000292	0.00048	CcSEcCtD
Busulfan—Asthenia—Methotrexate—colon cancer	0.000284	0.000467	CcSEcCtD
Busulfan—Pruritus—Methotrexate—colon cancer	0.00028	0.000461	CcSEcCtD
Busulfan—Diarrhoea—Methotrexate—colon cancer	0.000271	0.000446	CcSEcCtD
Busulfan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000265	0.00333	CbGpPWpGaD
Busulfan—MGST2—Metabolism—ABCB1—colon cancer	0.000265	0.00332	CbGpPWpGaD
Busulfan—Dizziness—Methotrexate—colon cancer	0.000262	0.000431	CcSEcCtD
Busulfan—MGST2—Metabolism—TYMS—colon cancer	0.00026	0.00326	CbGpPWpGaD
Busulfan—Vomiting—Methotrexate—colon cancer	0.000252	0.000414	CcSEcCtD
Busulfan—Rash—Methotrexate—colon cancer	0.00025	0.000411	CcSEcCtD
Busulfan—Dermatitis—Methotrexate—colon cancer	0.00025	0.00041	CcSEcCtD
Busulfan—GSTP1—Cellular responses to stress—CDKN1A—colon cancer	0.00025	0.00313	CbGpPWpGaD
Busulfan—Headache—Methotrexate—colon cancer	0.000248	0.000408	CcSEcCtD
Busulfan—GSTP1—Cellular responses to stress—EP300—colon cancer	0.000238	0.00298	CbGpPWpGaD
Busulfan—Nausea—Methotrexate—colon cancer	0.000235	0.000387	CcSEcCtD
Busulfan—GSTA1—Metabolism—ABCB1—colon cancer	0.000225	0.00282	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—VEGFA—colon cancer	0.000225	0.00282	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—TYMS—colon cancer	0.000221	0.00277	CbGpPWpGaD
Busulfan—MGST2—Metabolism—PPARG—colon cancer	0.000184	0.00231	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—TP53—colon cancer	0.00017	0.00213	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—PPARG—colon cancer	0.000157	0.00196	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—ABCB1—colon cancer	0.000152	0.0019	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—TYMS—colon cancer	0.000149	0.00187	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—ABCB1—colon cancer	0.000148	0.00185	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—TYMS—colon cancer	0.000145	0.00182	CbGpPWpGaD
Busulfan—MGST2—Metabolism—PTGS2—colon cancer	0.000145	0.00181	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—ABCB1—colon cancer	0.000126	0.00158	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—TYMS—colon cancer	0.000123	0.00155	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—PTGS2—colon cancer	0.000123	0.00154	CbGpPWpGaD
Busulfan—MGST2—Metabolism—EP300—colon cancer	0.00012	0.00151	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—CA7—colon cancer	0.000111	0.0014	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—PPARG—colon cancer	0.000106	0.00133	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—PPARG—colon cancer	0.000103	0.00129	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—EP300—colon cancer	0.000102	0.00128	CbGpPWpGaD
Busulfan—MGST2—Metabolism—PIK3CA—colon cancer	8.91e-05	0.00112	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—PPARG—colon cancer	8.75e-05	0.0011	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—PTGS2—colon cancer	8.32e-05	0.00104	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—PTGS2—colon cancer	8.09e-05	0.00101	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—PIK3CA—colon cancer	7.58e-05	0.000949	CbGpPWpGaD
Busulfan—MGST2—Metabolism—AKT1—colon cancer	7.28e-05	0.000912	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—EP300—colon cancer	6.92e-05	0.000867	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—PTGS2—colon cancer	6.88e-05	0.000862	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—ODC1—colon cancer	6.75e-05	0.000846	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—CHST5—colon cancer	6.75e-05	0.000846	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—EP300—colon cancer	6.73e-05	0.000843	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—AKT1—colon cancer	6.19e-05	0.000776	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—EP300—colon cancer	5.72e-05	0.000717	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—PIK3CA—colon cancer	5.12e-05	0.000641	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—PIK3CA—colon cancer	4.98e-05	0.000624	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—PIK3CA—colon cancer	4.23e-05	0.00053	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—AKT1—colon cancer	4.18e-05	0.000524	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—AKT1—colon cancer	4.07e-05	0.00051	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—AKT1—colon cancer	3.46e-05	0.000433	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—ABCB1—colon cancer	1.78e-05	0.000224	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—TYMS—colon cancer	1.75e-05	0.00022	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PPARG—colon cancer	1.24e-05	0.000156	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PTGS2—colon cancer	9.76e-06	0.000122	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—EP300—colon cancer	8.12e-06	0.000102	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PIK3CA—colon cancer	6.01e-06	7.53e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—AKT1—colon cancer	4.91e-06	6.15e-05	CbGpPWpGaD
